Phase 1, Open-label Study of the Safety, Tolerability, and Histological Effect of Single Doses of ATX-101 (Sodium Deoxycholate for Injection) Administered in Abdominal Fat in Subjects Undergoing Abdominoplasty
Latest Information Update: 20 Apr 2020
At a glance
- Drugs Deoxycholic acid (Primary)
- Indications Subcutaneous fat disorders
- Focus Therapeutic Use
- Sponsors Kythera Biopharmaceuticals
- 20 Apr 2020 New trial record